(b) The accessibility and affordability for all, without discrimination, including the most vulnerable or socially disadvantaged groups of the population, of pharmaceutical products or medical technologies used to treat pandemics such as HIV/AIDS, tuberculosis and malaria or the most common opportunistic infections that accompany them;
(b) 使所有人，包括最脆弱或在社会上处于最不利地位的群体，均能不受歧视地获得和负担得起用于治疗艾滋病毒/艾滋病、结核病和疟疾等大流行病或最常见的伴生机会感染的药品或医疗技术；